<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities and Exchange Act of 1934
(Amendment No. 8)*
ABIOMED, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
003654 10 0
- --------------------------------------------------------------------------------
(CUSIP Number)
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
[_] Rule 13d-1(b)
[_] Rule 13d-1(c)
[_] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act
(however, see the Notes).
Page 1 of 6 pages
<PAGE>
- ------------------------------ ------------------------------
CUSIP NO. 003654 10 0 Page 2 of 6 Pages
- ------------------------------ ------------------------------
- ------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS.
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
Dr. David M. Lederman
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
U.S.A.
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 595,277 shares
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
0 shares
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 595,277 shares
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
0 shares
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
595,277 shares
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[X]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
11
6.9%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
IN
- ------------------------------------------------------------------------------
Page 2 of 6 pages
<PAGE>
- ------------------------------ ------------------------------
CUSIP NO. 003654 10 0 Page 3 of 6 Pages
- ------------------------------ ------------------------------
- ------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS.
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
Ms. Natalie F. Lederman
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4
U.S.A.
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5
NUMBER OF 675,923 shares
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6
0 shares
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7
REPORTING 675,923 shares
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8
0 shares
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9
675,923 shares
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10 (SEE INSTRUCTIONS)
[X]
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11
7.8%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
12
IN
- ------------------------------------------------------------------------------
Page 3 of 6 pages
<PAGE>
Item 1(a)
Name of Issuer: ABIOMED, Inc.
Item 1(b)
Address of Issuer's Principal Executive Offices: 33 Cherry Hill Drive, Danvers,
Massachusetts 01923
Item 2(a)
Name of Person Filing: David M. Lederman and Natalie F. Lederman
Item 2(b)
Address of Principal Business Office or, if none, Residence: 33 Cherry Hill
Drive, Danvers, Massachusetts 01923
Item 2(c)
Citizenship: USA
Item 2(d)
Title of Class of Securities: Common Stock, $.01 par value
Item 2(e)
CUSIP Number: 003654 10 0
Item 3
Not Applicable
Item 4
Ownership:
(a) Amount Beneficially Owned: David M. Lederman owns 595,277 shares of
Common Stock. Natalie Lederman, his spouse, owns 675,923 shares of
Common Stock. Each of Dr. Lederman and Ms. Lederman disclaims
beneficial ownership of the shares held by the other.
(b) Percent of Class: Dr. Lederman: 6.9%
Ms. Lederman 7.8%
-----
Total: 14.7%
Page 4 of 6 pages
<PAGE>
(c) Number of Shares as to which such person has:
(i) sole power to vote or to direct the vote:
Dr. Lederman: 595,277 shares
Ms. Lederman 675,923 shares
---------
Total: 1,271,200
(ii) shared power to vote or to direct the vote: 0 shares
(iii) sole power to dispose or to direct the disposition of:
Dr. Lederman: 595,277 shares
Ms. Lederman 675,923 shares
---------
Total: 1,271,200
(iv) shared power to dispose or to direct the disposition of:
0 shares
Item 5
Ownership of Five Percent or Less of Class: Not Applicable
Item 6
Ownership of More than Five Percent on Behalf of Another Person: Not Applicable
Item 7
Identification and Classification of the Subsidiary Which Acquired the Security
Being Reported on By the Parent Holding Company: Not Applicable
Item 8
Identification and Classification of Members of the Group: Not Applicable
Item 9
Notice of Dissolution of Group: Not Applicable
Item 10
Certification: Not Applicable
Page 5 of 6 pages
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 1999 February 11, 1999
- ----------------- -----------------
Date Date
/s/David M. Lederman /s/Natalie F. Lederman
- -------------------- ----------------------
Signature Signature
David M. Lederman Natalie F. Lederman
- -------------------- ---------------------
Name Name
Page 6 of 6 pages
